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1. Introduction 
Cerebral ischemia is a serious dynamic event in the brain involving heterogeneous cell 
types. Neuroprotective agents represent a potential approach for the treatment of acute 
stroke. Presently, recombinant tissue plasminogen activator (rtPA) is the only drug that is 
approved for the management of acute ischaemic stroke, except for the antioxidant 
Edaravone in Japan (Yoshida et al., 2006). Although stroke patients can receive rtPA therapy 
within the initial 3 h therapeutic window, there is an increased risk of intracranial 
haemorrhage, disruption of the blood brain barrier, seizures, or the progression of neuronal 
damage (Laloux, 2001). Thus, there is a continued need to explore novel neuroprotective 
strategies for the management of ischemic stroke. A large number of therapeutic agents 
have been tested, including N-methyl-D-aspartate receptor antagonists, calcium channel 
blockers, and antioxidants, for the management of stroke, but none has provided significant 
neuroprotection in clinical trials (Green et al., 2003; Kidwell et al., 2001). 
Therapeutic hypothermia lowers a patient‘s body temperature in order to reduce the risk of 
the ischemic injury to the brain following a period of insufficient blood flow (Lampe and 
Becker, 2011; Yenari and Hemmen, 2010). The normal human adult body temperature is 
between 34.4–37.8°C and is maintained at a constant level through homeostasis or 
thermoregulation. Therapeutic hypothermia is defined as the artificial maintenance of the 
body temperature at <35°C and is subdivided into 4 different categories: mild (32–35°C), 
moderate (28–32°C), severe (20–28°C), and profound (<20°C). Nowadays, mild-to-moderate 
hypothermia (31–33°C) is usually applied for neuroprotection. The practical usage of 
hypothermia for clinical purposes was begun by the ancient Egyptians, Greeks, and Romans 
(Polderman, 2004). Ancient people observed the clinical usefulness of hypothermia for 
accidents and applied it to various diseases/symptoms. Modern clinical interest in 
hypothermia began in the 1930s with the description of the successful rescue of a drowned 
person with hypothermia after a prolonged period of asphyxia. After the first scientific 
report in 1945, which described the clinical application of hypothermia to patients with a 
severe head injury, hypothermia was subsequently applied to intracerebral aneurysm 
surgery and cerebral protection during complete circulatory arrest.  
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In the past few decades, the neuroprotective effects of hypothermia have been well 
established in experimental animals (Kawai et al., 2000; Miyazawa et al., 2003; Yanamoto et 
al., 2001) and in patients with cardiac arrest (THCASG, 2002 and Bernard et al., 2002). The 
initiation of moderate hypothermia within a few hours of severe ischemia can reduce the 
subsequent neuronal death and profoundly improve behavioural recovery. Although 
hypothermia is the only clinical intervention that appears to be neuroprotective after the 
initial injury, its key mechanisms have not been clarified. In other words, the 
neuroprotective effects of hypothermia provide many insights into the pathology of stroke, 
and thus may reveal clues for novel drug targets. 
2. Neuroprotection against cerebral ischemia by hypothermia 
Ischemia and cerebral hemorrhage are the two main causes of strokes. Ischemia accounts for 
~85% of all reported incidents of stroke, and occurs when a thrombus or embolus blocks 
cerebral blood flow, resulting in cerebral ischemia and consequently neuronal damage and 
cell death. Conversely, hemorrhage occurs following the rupture of any blood vessel in the 
brain, resulting in rapid cerebral damage, and accounts for the remaining 15% of stroke 
cases. In each situation, the interruption of blood flow to the brain results in the reduced 
supply of oxygen and nutrients to the neurons. At the molecular level, the pathophysiology 
of ischemia is complicated and involves multiple sequential steps: progressive neural injury 
beginning with the activation of glutamate receptors, followed by the production and 
release of proinflammatory cytokines, nitric oxide (NO), free oxygen radicals, and proteases. 
As a result, neurons in an ischemic brain suffer irreversible and fatal damage. From the 
electrophysiological viewpoint, neurons depolarize massively giving rise to anoxic 
depolarization (Bureš et al., 1974) or to peri-infarct depolarizations (Gyngell et al., 1995). 
They are both characterized by swelling of neurons, massive influx of Na+ and Ca2+ into 
neurons, massive release of K+ into the interstitial space, release of glutamate, acidification 
of the tissue (Somjen, 2001; Dreier, 2011; Balestrino, 1995).  
The lack of blood supply results in two identifiable areas, namely the core and the 
penumbra. The core is a neuronal dead area that is not therapeutically accessible, whereas 
the penumbra is a still salvageable zone (Bandera et al., 2006). As a consequence of the 
reduced blood supply inside the core, adenosine triphosphate (ATP) levels are reduced, 
leading to the depression of cellular metabolism. Energy loss results in impaired ion 
homeostasis, which leads to rapid depolarization and a large influx of calcium and 
potassium ions. The increased levels of intracellular calcium induces the activation of 
excitotoxic glutamatergic transmission, NO synthase, caspase, xanthine oxidase, and the 
release of reactive oxygen species. Glutamate release activates phospholipases, 
phospholipid hydrolysis, and the release of arachidonic acid. The generation of free radicals 
and lipid peroxidation and the activation of immediate early genes, such as c-fos, c-jun, and 
the inflammatory cascade, lead to progressive ischemic damage, resulting in necrotic as well 
as apoptotic cell death. Conversely, the penumbra represents viable tissue surrounding the 
core and receives a trivial amount of blood from collateral arteries; therefore, the penumbra 
is the target for drug intervention and has the potential for recovery. 
Precisely controlled mild hypothermia has been proven to have neuroprotective properties 
and reduces the risk of the detrimental effects that often occur during profound 
hypothermia. Large numbers of the phenomena observed in ischemic brains can be 
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
45 
ameliorated by hypothermia, including the reduction of oxygen radical production, with the 
subsequent reduction in peroxidase damage to lipids, proteins, and DNA, thereby 
supporting the behavioral recovery of patients. Hypothermia also decreases microglial 
activation, ischemic depolarization, cerebral metabolic demand for oxygen, and the release 
of glycerin and excitatory amino acids. We and others have demonstrated that inflammation 
potentiates cerebral ischemic injury and that hypothermia can reduce inflammation by 
suppressing the infiltration of neutrophils into ischemic regions (Ohta et al., 2007; Shintani 
et al., 2011; Terao et al., 2009; Zheng and Yonari, 2004). Furthermore, the inhibition of 
reactive oxygen species production by leukocytes and microglia in the ischemia brain (Kil et 
al., 1996), NF-κB activation (Han et al., 2003), neutrophil infiltration (Wang et al., 2002), and 
cytochrome c release (Yenari et al., 2002) has been also reported in hypothermia-treated 
ischemic rat brains. 
Recently, Lin et al., (2011) reported that whole-body hypothermia broadens the therapeutic 
window of intranasally administered recombinant human insulin-like growth factor 1 (IGF-
1) in a neonatal rat cerebral hypoxia–ischemia model. They ligated the right common carotid 
artery of postnatal day 7 rat pups, followed by 8% oxygen inhalation for 2 h. After the 
hypoxia-ischemia treatment, the pups were divided into 2 groups and maintained under 
different temperatures, room temperature (24.5 ± 0.2°C) and a cool environment (21.5 ± 
0.3°C), for 2 or 4 h before being returned to room temperature. IGF-1 was administered 
intranasally at 1 h intervals starting at 0, 2, or 4 h after hypothermia. Although the 
administration of hypothermia or IGF-1 alone at 2 h after hypoxia-ischemia treatment did 
not provide neuroprotection, the combined treatment of hypothermia and IGF-1 
significantly protected the neonatal rat brain from hypoxia-ischemia injury. Hypothermia 
extended the therapeutic window of IGF-1 to 6 h after hypoxia-ischemia. It was observed 
that the combination therapy decreased the infiltration of polymorphonuclear leukocytes, 
the activation of microglia/macrophages, and the attenuation of nuclear factor kappa-B 
(NF-κB) activation. These findings broaden the potential application of hypothermia, i.e., 
not only for its neuroprotective effects but also for its synergistic effects by the combined use 
of hypothermia with already existing therapeutic drugs. 
3. Molecular mechanisms of hypothermia-induced neuroprotection 
3.1 Proteins influenced by hypothermia 
The detailed molecular mechanisms underlying the neuroprotection induced by 
hypothermia against ischemia have been approached by degrees. In most cases, molecules, 
whose expression is known to be affected by ischemia, have been identified and the effects 
of hypothermia on the molecule have been explored retrospectively. Table 1 lists the 
molecules whose expression is affected by hypothermia during ischemia and/or 
reperfusion. The majority of these proteins are apoptosis, inflammation-related, and 
signalling molecules, such as kinases and transcription factors. For example, apoptosis-
related molecules, such as B-cell lymphoma 2 (Bcl2), Bcl-associated X protein (Bax), 
caspases, calpains, cytochrome c, and Fas/Fas ligand (FasL), are up- or down-regulated by 
hypothermia in accordance with its neuroprotective effect, thereby preventing neuronal cell 
death. Inflammatory molecules, such as tumor necrosis factor alpha (TNF), interleukin 
(IL)-1, IL-6, monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-3  
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Molecule Hypothermia
Expression 
Ischemia/observation Reference 
Ischemia Hypothermia
IL-1 33°C culture N.D. Increase In vitro cell culture Yanagawa  
et al., 2002 
IL-1, TNF 
2 h 
hypothermia, 
started 20 
min after ET-
1 injection 
Increase Decrease 
Rat endothelin (ET)-1-
induced transient focal 
cerebral ischemia; 
hypothermia reduced 
astrogliosis at 1 and 3 d 
after stroke onset. 
Ceulemans  
et al., 2011 
IL-1TNF 33°C culture Increase Decrease 
In vitro cell culture;  
30 h oxygen– 
glucose deprivation 
(OGD) 
Webster et al., 2009 
IL-6 33°C culture N.D. Decrease In vitro cell culture Yanagawa  
et al., 2002 
IL-18 
32°C for 24 h 
after hypoxia-
ischemia 
Increase Decrease Hypoxia-ischemia Fukui et al., 2006 
MIP-3 34°C after 
MCAO 
Increase Decrease 2 h MCAO Terao et al., 2009 
IL-1, IL-6, IL-
10, TNF, 
ICAM-1 
33°C for 24 h Increase Decrease 
Pigs were subjected to 
cardiac arrest following 
temporary coronary 
artery 
occlusion.support. 
Meybohm  
et al., 2010 
MCP-1 
34 °C after 
MCAO 
Increase Decrease 2 h MCAO Ohta et al., 2007 
Intercellular 
adhesion 
molecule-1 
(ICAM-1) 
33°C etc. Increase Decrease 
 
2 h MCAO; extracellular 
signal-regulated  
kinase-1/2 (ERK-1/2) 
activation, and 
induction of leukocyte 
infiltration and 
inflammatory reaction 
by ischemia were 
inhibited by 
hypothermia. 
 
Choi et al., 2011; 
Inamasu  
et al., 2001;  
Koda et al., 2010 
NF-B 33°C for 2 h 
after MCAO 
No change No change 
2 h MCAO; NF-kB  
was translocated  
from cytoplasm to 
nucleus  
by hypothermia. 
Han et al., 2003 
NF-B's 
inhibitory 
protein (IkB-) 
33°C for 2 h 
after MCAO 
Increase Decrease 2 h MCAO Han et al., 2003 
IkB-, NOS, 
TNF 30-34°C Increase Decrease 
Phosphorylation of  
IkB- was suppressed 
by hypothermia. 
Yenari et al., 2006 
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Molecule Hypothermia
Expression 
Ischemia/observation Reference 
Ischemia Hypothermia
Bcl-2 30-34°C Down Increase 1 h hypoxia-ischemia 
etc. 
Eberspacher  
et al., 2005;  
Jieyong et al., 2006; 
Zhao et al., 2004; 
Yenari et al., 2002; 
Zhang et al., 2001 
Bcl-2 
31-32°C 
hypothermia 
for 60 min 
after MCAO 
N.D. Increase 
Rat global cerebral 
ischemia (20 min); the 
mortality in rats was 
evaluated at 72 h and 
168 h reperfusion. 
Zhang et al., 2010 
Bcl2 33°C culture Increase Decrease 
In vitro cell culture; 5 h 
OGD at 37°C; human 
umbilical vein 
endothelial cells were 
used in this study.
Yang et al., 2009 
Bax 33°C culture Decrease Increase 
In vitro cell culture; 5 h 
OGD at 37°C; human 
umbilical vein 
endothelial cells were 
used in this study. 
Yang et al., 2009 
Bax 
34°C  during 
ischemia
Increase Decrease 
Bcl‐2, p53, and Mdm‐2; 
no change
Eberspacher  
et al, 2003, 2005 
Fas, FasL 
33°C during 
ischemia etc. 
Increase Decrease 
2h MCAO; soluble FasL 
(sFasL) was decreased 
by hypothermia, while 
membrane-bound FasL 
(mFasL) increased.
Liu et al., 2008; 
Phanithi et al., 2000 
Akt 
34°C  after 
ischemia 
Increase Decrease 
Hypoxia-ischemia for  
1 h 
Tomimatsu  
et al., 2001 
Caspase-3 30-34°C Increase Decrease 1 h hypoxia-ischemia 
etc. 
Fukuda  
et al., 2001;  
Pabello  
et al., 2005; 
Phanithi  
et al., 2000; 
Tomimatsu  
et al., 2001 
Caspase 8 
33°C during 
ischemia
Increase Decrease 2h MCAO Liu et al., 2008 
Caspase-3/9 
33°C for 10 
min before 
ischemia and 
maintained  
3 h after 
reperfusion
Increase Decrease 
10 min MCAO and 
hypotention 
Zhao  
et al., 2004, 2005 
Calpain 
32°C  for 10 
min before 
and during 
reperfusion 
Increase Decrease 
3 h MCAO and 24 h 
reperfusion 
Liebetrau  
et al., 2004 
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Molecule Hypothermia
Expression 
Ischemia/observation Reference 
Ischemia Hypothermia
Cytochrome c, 
AIF 
30 or 33°C for 
2 h during 
and/or after 
MCAO 
N.D. N.D. 
2 hr MCAO; 
cytochrome c release 
and AIF translocation 
from mitochondria to 
nuclei were stimulated 
by hypothermia. 
Zhao et al., 2007 
Cytochrome c, 
AIF 
34 or 36°C Increase Decrease 
50 min MCAO; 
cytochrome c release 
and AIF translocation 
from mitochondria to 
nuclei were stimulated 
by hypothermia. 
Zhu et al., 2006 
Akt 
30°C for 10 
min before 
ischemia and 
maintained 
for 1 h after 
ischemia 
N.D. N.D. 
1 h MCAO; Akt activity 
was inhibited by 
ischemia and stimulated 
by hypothermia.  
Zhao et al., 2005 
c-Fos, AP-1 
Cold room 
(1°C) during 
MCAO 
Increase Decrease 
1 h MCAO; c-Jun 
expression was not 
affected by 
hypothermia. 
Akaji et al., 2003 
AMPK 
(phospho-
rylation) 
 
N.D. N.D. 
Ischemia-induced 
phosphorylation of 
AMPK was inhibited by 
hypothermia.
Li et al., 2011 
cold-inducible 
RNA-binding 
protein (CIRP) 
Moderate 
(30 ± 2°C) 
hypothermia 
for 2 h 
Increase Increase 20 min MCAO Liu et al., 2010 
p53 31-32°C N.D. Decrease 
Rat global cerebral 
ischemia (20 min); the 
mortality in rats was 
evaluated at 72 h and 
168 h reperfusion.  
Zhang et al., 2010 
p53, PUMA, 
NOXA 
33°C Increase Decrease 
2 h MCAO; DNA 
damage-dependent 
signaling events, 
including NAD 
depletion, p53 
activation, and 
mitochondrial 
translocation of PUMA 
and NOXA 
Ji et al., 2007 
hypoxia-
inducible 
factor-1 (HIF-1) 
28–32°C 
culture 
Increase Decrease In vitro cell culture Tanaka et al., 2010 
high-mobility 
group box 1 
(HMGB1) 
32°C N.T. Decrease 
 
Koda et al., 2010 
Hsp70 Increase Increase 2 h MCAO Terao et al., 2009 
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Molecule Hypothermia
Expression 
Ischemia/observation Reference 
Ischemia Hypothermia
Agrin, SPARC 
(BM-40, 
osteonectin) 
32° C Decrease Increase Transient 20 min 
forebrain ischemia 
Baumann  
et al., 2009 
GSK3 33°C N.D. Decrease Global cerebral ischemia Kelly et al., 2005 
GSK 3 
Moderate 
hypothermia 
(30°C) 
blocked 
degradation 
of total GSK 
3 
N.D. N.D. 
Dephosphorylated after 
stroke in normothermia
Zhang et al., 2008 
-catenin 
 
N.D. N.D. 
Phosphorylation of 
b-catenin was increased 
and degraded by 
ischemia. Hypothermia 
did not inhibit the 
phosphorylation, but it 
blocked degradation in 
the ischemic penumbra.
Zhang et al., 2008 
MLK3, 
MKK4/7, 
JNK3, c-Jun, 
FasL 
32°C 
hypothermia 
for 10 min 
before 
ischemia and  
maintained 
for 3 h after 
ischemia 
Increase Decrease 
Alternation of the 
assembly of the GluR6-
PSD95-MLK3 signaling 
module 
Hu et al., 2008 
Galanin 33°C Decrease Increase 60 min transient MCAO Theodorsson  
et al., 2008 
COX-2 33-34°C Increase Decrease Global ischemic insult Xiang  
et al., 2007 
MMP-2, MMP-
9 
33°C etc. Increase Decrease 90 min MCAO 
Lee  
et al., 2005;  
Nagel  
et al., 2008 
TIMP-2 
33°C during 
ischemia
N.D. Increase 2 h MCAO Lee et al., 2005 
BDNF 
33-34°C for 
24 h 
Decrease Increase Permanent MCAO Xie et al. 2007 
-PKCs, 
CaM kinase II 
30 min of 
ischemia 
followed by 
60 min of 
reperfusion 
N.D. N.D. 
30 min ischemia 
followed by 60 min 
reperfusion; 
hypothermia inhibited 
translocation of CaM 
kinase II and 
-PKC 
Harada et al., 2002 
PKC 30°C during 
MCAO 
Decrease Increase 1 h MCAO 
Shimohata  
et al., 2007 
PKC 30°C during 
MCAO 
Increase Decrease 1 h MCAO 
Shimohata  
et al., 2007 
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Molecule Hypothermia
Expression 
Ischemia/observation Reference 
Ischemia Hypothermia
hypoxanthine 
phosphoribosyl 
transferase 
(HPRT) 
33-34°C 
throughout 
identical 
injury and 
reperfusion 
periods
No change No change 
8 min hypoxia or 
ischemia, and 30 min or 
4 h of cerebral 
reperfusion 
Cherin et al., 2006 
calcium 
sensing 
receptor 
(CaSR) 
33°C for 3 h 
after 
reperfusion 
Increase Decrease 
10 min ischemia 
followed by 1-3 d 
reperfusion 
Kim et al., 2011 
Inhibitory 
gamma-
aminobutyrica
cid-B receptor 
1 (GABA-B-R1) 
33°C for 3 h 
after 
reperfusion 
Decrease Increase 
10 min ischemia 
followed by 1-3 d 
reperfusion 
Kim et al., 2011 
AMPA 
receptor 
subunit GluR2 
1 h after 
reperfusion at 
32°C, then 
warmed to 
34°C and 
36°C in a 
step-by-step 
manner. 
Decrease Increase 1 h MCAO 
Colbourne  
et al., 2003 
SOD 
33°C during 
ischemia 
Increase Decrease 2 h MCAO Maier et al., 2002 
iNOS 
33°C during 
or after 
ischemia 
Increase Decrease 1 h MCAO Han et al., 2002 
GPR78 34±0.5°C  Decrease Increase 
ischemic for 15 min and 
then reperfused for  
3 h under 
Aoki et al., 2001 
74 proteins 
including 
glycolysis, 
plasticity, and 
redox-related 
proteins. 
33°C during 
ischemia 
N.D. 
Glycolysis 
and 
plasticity-
related 
proteins were 
preserved but 
redox-related 
proteins were 
lowered by 
hypothermia.
15 min ischemia Teilum et al., 2007 
N.D. = not determined. 
Table 1 Proteins of which expression and/or modification are altered by ischemia and 
hypothermia 
alpha (MIP-3), and NF-B, are also up-regulated after middle cerebral artery occlusion 
(MCAO) and down-regulated by hypothermia. These molecules are considered to enhance 
cell damage through the activation of microglia and/or astrocytes. Recently, more direct 
and dynamic inflammatory changes have been speculated to be induced by hypothermia 
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during ischemia. And now it has become clear that the neuroinflammatory response could 
be detrimental and that even peripheral immune responses can be regulated by the brain 
(Ceulemans et al., 2011). 
Another type of change evoked by hypothermia in ischemic brains is protein modification. 
For instance, Li et al. (2011) reported that hypothermia reduced the activation of 5′ 
adenosine monophosphate-activated protein kinase (AMPK), a ubiquitously distributed 
kinase, by the dephosphorylation of its regulatory residues in ischemic mice. They showed 
that hypothermic neuroprotection was ameliorated by compound C, an AMPK inhibitor, 
and that genetic deletion of one of the catalytic isoforms of AMPK completely reversed the 
effects of hypothermia on stroke outcome after acute and chronic survival. Their study 
provides evidence that hypothermia exerts its protective effects, in part, by inhibiting 
AMPK activation, at least in experimental focal stroke. AMPK is known to participate in an 
energy sensing cascade and to serve as a master regulator of metabolism in response to ATP 
depletion. Recently, additional roles of AMPK in a variety of other cellular processes have 
been revealed, in the cytoplasm and nucleus, as a controllor of cell polarity and a 
transcriptional regulator. A more interesting function of AMPK in signaling pathways is its 
role as a responder to cellular stress and damage, and the relevance of AMPK signaling in 
various diseases is becoming a hot topic in the investigation of ischemic physiology. 
3.2 Inflammatory proteins 
3.2.1 Cytokines 
Neuroinflammation is involved in the pathogenesis of many central nervous system (CNS) 
diseases. In stroke, excess inflammatory activation results in brain injury and ultimately causes 
severe neuronal apoptosis (Zheng and Yonari, 2004). Anti-inflammatory therapies using 
immunosuppressants (Furuichi et al., 2004) or biogenetics, e.g., an anti-ICAM-1-neutralizing 
antibody (Matsuo et al., 1994), have been applied in preclinical and clinical trials. In this 
context, the effect of hypothermia on neuroinflammation has been vigorously explored. 
Webster et al. (2009) measured the levels of proinflammatory cytokines, such as TNF-ǂ and 
IL-ǃ, in microglial culture supernatants after stimulation with lipopolysaccharide (LPS) or 2 
h oxygen–glucose deprivation (OGD) exposure followed by 24 h reperfusion. There was a 
marked increase in the production and release of inflammatory cytokines by microglia 
following LPS stimulation and OGD, which was attenuated by hypothermia. Glutamate, a 
major neurotransmitter, was also released from microglia stimulated with LPS at 37°C, but 
reduced levels were observed when they were stimulated with LPS at 33°C. IL-18 is another 
proinflammatory cytokine that may contribute to brain injury. Fukui et al. (2006) showed 
that the effects of hypothermia treatment after hypoxia-ischemia (rectal temperature of 32°C 
for 24 h) on IL-18 expression. IL-18 expression in the ipsilateral hemispheres of the 
normothermia group significantly increased at 72 h after hypoxia-ischemia compared with 
controls; however, IL-18 expression was significantly decreased in the hypothermia group. 
NF-kB is a transcription factor that is activated after cerebral ischemia. The activation of NF-
kB leads to the expression of many inflammatory genes involved in the pathogenesis of 
stroke. Yenari and Han (2006) showed that hypothermia decreases the translocation of NF-
kB from the cytoplasm to nucleus and its binding activity to NF-kB regulatory proteins. 
Mild hypothermia appears to suppress the phosphorylation of IkB-, an NF-kB inhibitory 
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protein, by decreasing the expression and activity of IkB kinase- (IKK). As a consequence, 
hypothermia suppressed the expression of 2 NF-kB target genes, inducible nitric oxide 
synthase (iNOS) and TNF. 
We previously determined that the therapeutic time window of post-ischemia mild 
hypothermia was 4 h after reperfusion (Ohta et al., 2007). Thus, we considered that the gene 
expression changes that occur before the 4 h time point might be important for the 
neuroprotective effect induced by mild hypothermia, even though the neuroprotection 
afforded by hypothermia alone during this period was found to be insufficient. After a 
series of investigations with hypothermia, we hypothesized that the gene expression 
changes that were observed after the 4 h timepoint, following the discontinuation of 
hypothermia, are related to the ischemic damage detected at 2 d after MCAO. Genes that 
were upregulated after the 4 hr timepoint, including early growth response-2 (Egr-2), 
neurotransmitter-induced early genes-1 (Ania-1), and macrophage inflammatory protein-3 (MIP-
3, were found to be important for the neuroprotection afforded by hypothermia. We 
selected the following 12 genes that might exert substantial neuroprotective activity: c-Fos, 
Egr-1, Egr-4, neuron-derived orphan receptor-1 (Nor1), MAP kinase phosphatase-1 (MKP-1), MKP-
CPG21, MIP-3, monocyte chemotactic protein-1 (MCP-1), brain-derived neurotrophic factor 
(BDNF), IL-1, Ania-1, and Ania-7. Egr-1 is known as a master switch that is activated by 
ischemia to trigger the expression of pivotal regulators of inflammation, e.g., IL-1, MCP-1, 
and MIP-2, in addition to coagulation and vascular hyperpermeability. 
3.2.2 Chemokines 
Chemokines are also well known to be detrimental factors in the brain. For instance, MCP-1 
is considered to be a promising drug target due to its possible role in exacerbating ischemic 
injury, controlling blood-brain barrier permeability, and driving leukocyte infiltration into 
the brain parenchyma in stroke (Dimitrijevic et al., 2006, 2007; Schilling et al., 2009). We have 
observed that MCP-1 gene expression was upregulated by ischemia and that the expression 
stimulated by ischemia was supressed by hypothermia (Ohta et al., 2007). 
We further conducted comprehensive gene expression analyses of ischemic rat brains with or 
without hypothermia by using a rat ischemia-reperfusion model in order to elucidate the 
underlying mechanisms and discover novel target molecules. In this study, we revealed that 
cerebral MIP-3ǂ and CC-chemokine receptor 6 (CCR6) genes were significantly induced in the 
core and penumbra regions of MCAO rat brains, and hypothermia suppressed the expression 
of both genes (Terao et al., 2009). MIP-3ǂ is expressed in macrophages, dendritic cells, and 
lymphocytes. Depending on the conditions, MIP-3ǂ can act constitutively or inducibly and 
serves as a chemoattractant, especially in epithelial immunological systems such as those of 
the skin and mucosa (Charbonnier et al., 1999; Cook et al., 2000). In the CNS, MIP-3ǂ 
expression has been reported in autoimmune encephalomyelitis (Ambrosini et al., 2003) and 
stroke patients (Lu et al., 2004; Utans-Schneitz et al., 1998), but its full role has not yet been 
determined. CCR6, the sole receptor for MIP-3ǂ, is expressed in multiple leukocyte subsets, 
and is implicated in diverse inflammatory responses in animal models, such as allergic airway 
disorders, inflammatory bowel disease, and autoimmune encephalitis (Schutyser et al., 2003). 
Strikingly, the intracerebral administration of an anti-rat MIP-3ǂ-neutralizing antibody 
significantly reduced infarct volumes in MCAO rats compared with those of vehicle- and 
control mouse IgG-treated rats, suggesting that MIP-3ǂ-CCR6 signaling is dominant in the 
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
53 
neuroinflammatory cascades of brain ischemia. Interestingly, the administration of MIP-3ǂ 
into the striatum induced CCR6 gene expression in a dose-dependent manner, but not CCR1 or 
CCR2 expression. The intrastriatal injection of IL-1ǃ and TNF-ǂ into control rats upregulated 
MIP-3 and CCR6 mRNA expression levels in a sequential fashion. Taken together with the 
robust induction of IL-1ǃ and TNF-ǂ in ischemic brains during an acute phase of MCAO prior 
to MIP-3ǂ expression, these cytokines may directly evoke MIP-3ǂ production in the CNS. 
Furthermore, MIP-3 mRNA expression was markedly induced by IL-1ǃ and TNF-ǂ in rat 
astrocytes, but not in microglia or neurons. Astrocytes stimulated by ischemic stress turn into 
their active form, expressing glial fibrillary acidic protein (GFAP), and appear around the 
damaged area after ischemic injury (Zoli et al., 1997). Rat primary microglia constitutively 
express the CCR6 gene under normal culture conditions, while astrocytes and neurons do not. 
Interestingly, we found that the expression of iNOS and IL-1ǃ was induced in MIP-3ǂ-treated 
microglia. Microglia are activated and accumulate around the injured area following ischemia 
(Wood, 1995). We observed that MIP-3ǂ was produced by rat primary cultured astrocytes in 
response to IL-1ǃ and TNF-ǂ treatment, while hypothermia significantly suppressed the 
expression of both cytokines. Therefore, the activation of astrocytes and microglia may 
accelerate brain injury-induced neuroinflammation via MIP-3ǂ-CCR6 signaling, whereas 
hypothermia suppresses this signaling. The physiological roles of MIP-3ǂ-CCR6 signaling in 
the CNS have yet to be fully determined because various roles for chemokines in the brain 
have recently been proposed, e.g., neurotransmitters and neuromodulators (de Haas et al., 
2007; Rostène et al., 2007). The interactions between MIP-3ǂ-CCR6 signaling and other 
pathways involved in ischemic pathology, e.g., excitotoxicity, acidotoxicity, oxidative stress, 
and apoptosis, should also be examined.  
3.3 Apoptotic proteins 
Apoptosis is another important factor for ischemic damage because of its contribution to the 
cell death subsequent to ischemia/reperfusion injury (Broughton et al., 2009). To date, 
mitochondrial dysfunction, oxidative stress, and impaired cerebral energy metabolism have 
been observed during the neuronal cell death that is responsible for much of the poor 
neurologic outcome from these events. Recent studies using in vitro and in vivo neuronal cell 
death models point toward several molecular mechanisms that are either induced or 
promoted by the oxidative modification of macromolecules, including the consumption of 
cytosolic and mitochondrial nicotinamide adenine dinucleotide (NAD+) by poly-ADP ribose 
polymerase (PARP), opening of the mitochondrial inner membrane permeability transition 
pore, and the inactivation of key, rate-limiting metabolic enzymes, such as the pyruvate 
dehydrogenase complex. In addition, the relative abundance of proapoptotic proteins in 
immature brains and neurons, and particularly within their mitochondria, predisposes these 
cells to the intrinsic, mitochondrial pathway of apoptosis, which is mediated by the Bax- or 
Bak-triggered release of proteins into the cytosol through the mitochondrial outer 
membrane. On the basis of these cell dysfunction and death pathways, several approaches 
toward neuroprotection are being investigated that show promise for their future clinical 
application. These strategies include minimizing oxidative stress to avoid unnecessary 
hypoxia, promoting aerobic energy metabolism by the repletion of NAD+, and providing 
alternative oxidative fuels, e.g., ketone bodies, directly interfering with apoptotic pathways 
in mitochondria, and pharmacologically inducing antioxidant and anti-inflammatory gene 
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expression. Hypothermia is known to reduce oxidative stress, metabolic dysfunction, 
delayed neuronal death, and short- and long-term neurobehavioral impairment. However, 
despite successful clinical trials of hypothermia, its neuroprotective mechanisms have not 
been well investigated. 
We investigated the activity of apoptotic proteases, calpains, and caspase-3 in 2 h MCAO rat 
brains using ǂ-fodrin, a cytoskeletal protein enriched in the synaptosome-rich fraction, as a 
substrate for each (Fig. 1). ǂ-Fodrin is fragmented by calpains and caspase-3 to 145/150-kDa 
and 120-kDa cleavage products from its intact 240-kDa protein, respectively (Wang, 2000). 
Harada et al. (2002) reported that ischemia-reperfusion induced the proteolysis of -fodrin 
with the generation of the 150-kDa fragment, while hypothermia inhibited this ischemia-
reperfusion-induced proteolysis. As shown in Fig. 1, an anti-ǂ-fodrin antibody detected 
several bands, including the 240-kDa intact protein and the 145/150-kDa and 120-kDa 
breakdown products. We also detected the 145/150-kDa bands at 48 h after MCAO in 
normothermia. Surprisingly, mild hypothermia (34°C) did not change the density of those 
bands. These finding suggest that the inhibition of protein degradation by hypothermia is 
not dominant in our model or that ǂ-fodrin is not a suitable substrate to determine apoptotic 
degradation. 
 
Fig. 1. Lack of effect of hypothermia on ǂ-fodrin degradation in MCAO rat brains 
Protease activity in brain tissues of rats maintained at normothermic (37°C) or hypothermic 
(34°C) conditions at 0 or 48 h after MCAO and in control brain tissues was shown by the 
degree of ǂ-fodrin degradation. In controls, ǂ- fodrin was detected mainly as a 240-kDa (*) 
band, although ǂ-fodrin was severely degraded into 145/150- (**) and 120-kDa (#) bands in 
the core (A) and penumbra (B) regions. Unexpectedly, hypothermia did not affect the 
degradation of ǂ- fodrin in contralateral (C) regions in MCAO rat brains. 
3.4 Cold-inducible RNA-binding proteins 
Having some analogy to mild hypothermia, mammalian hibernation serves as a natural 
model of tolerance to extreme reductions of blood flow, energy consumption, and body 
temperature, and to the capacity to deliver oxygen to tissues at otherwise lethal levels 
(Frerichs et al, 1994; Frerichs and Hallenbeck, 1998). As hibernating animals suffer no CNS 
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damage or cellular loss because of these special adaptive changes (Carey et al, 2003; Storey, 
2003), the molecular mechanisms that regulate these adaptations are potential targets for 
drug discovery. Generally, low temperatures reduce the rate of enzymatic reactions, 
diffusion, and membrane transport due to the inhibition of chemical reaction rates. 
Although certain microorganisms are able to adapt to cold environments, apart from the 
over-expression of a defined set of cold-shock proteins, by the modification of enzyme 
kinetics, in mammalian cells, the molecular mechanisms that govern adaptation to mild 
hypothermia are not well known, although they may involve a series of events that 
modulate transcription, translation, the cytoskeleton, the cell cycle, and metabolic processes. 
Furthermore, it has been demonstrated that cells exposed to moderate hypothermia, even 
for short periods of time, have broad changes in their gene expression patterns. Upon 
exposure to moderate hypothermia, certain specific cold-shock proteins respond 
immediately to ensure that the cell rapidly adapts to the novel environmental conditions 
(Fujita, 1999). For decades, it was assumed that the proteins activated upon exposure to mild 
cold temperatures are somehow responsible for the general metabolic deceleration that 
occurs when mammalian cells are exposed to mild cold shock. Nonetheless, cold-shock 
proteins actually “facilitate” the accurate and enhanced translation of specific mRNAs at 
temperatures below physiological temperatures (Durandy, 2008). 
Several hypothermia-induced genes have been identified mainly by using in vitro cellular 
models. For example, Tanaka et al. (2010) showed that the exposure of cultured cells to 32°C 
for as long as 24 h suppressed the hypoxia-induced activation of hypoxia-inducible factor 1 
(HIF-1) and the subsequent upregulation of HIF-1 target genes, e.g., vascular endothelial 
growth factor (VEGF) or glucose transporter 1 (GLUT-1), although HIF-1 protein stability 
was not affected by hypothermic treatment. Yang et al. (2009) reported that hypothermia 
markedly reduced OGD-induced apoptosis in human umbilical endothelial cells (HUVEC), 
which was induced by changing the media of HUVEC subjected to OGD for 5 h with 
oxygenated media. The cells were then placed in an incubator for 0–20 h at normothermic 
(37°C) or hypothermic (33°C) conditions to mimic reperfusion. Hypothermia reduced the 
expression of cleaved caspase-3 and poly(ADP-ribose) polymerase (PARP), but, in contrast, 
it reversed the OGD-induced activation of Fas/caspase-8, the increase of Bax and decrease 
of Bcl-2, and the inhibition of JNK1/2 activation via MKP-1 induction, suggesting that 
hypothermia represses OGD-induced endothelial cell apoptosis by inhibiting the extrinsic- 
and intrinsic-dependent apoptotic pathways and the activation of JNK1/2. Lee et al. (2009) 
showed that moderate hypothermia (30°C) reduces ischemic damage after permanent distal 
MCAO in rats. They showed that early and delayed hypothermia blocked -protein kinase C 
(PKC) cleavage, suggesting that the degradation of proteins by caspases might be 
suppressed by hypothermia. 
We attempted to identify genes whose expression is specifically induced by mild 
hypothermia using cDNA subtraction between normothermia- and hypothermia-treated rat 
cortex-derived primary neurons. The culture temperature of the cells was lowered to 32˚C 
for 14 h and then increased to 37˚C. The cells were incubated for 0 (A) or 7 h (B) before their 
mRNA was collected. Control neurons were maintained at 37˚C for 21 h (C). We synthesized 
cDNA from each mRNA sample as described in our previous report (Terao et al., 2009) and 
generated a subtraction cDNA library for each condition. To identify the specific genes 
associated with mild hypothermia, we screened subtracted cDNAs between (A) and (C) or 
(B) and (C). We identified candidate genes whose expression were specifically induced in 
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cells incubated at 32˚C compared with controls. All of the genes thus obtained were 
different gene fragments of the same cold-inducible RNA-binding protein (CIRP) (data 
not shown). CIRP (also known as A18 hnRNP) is an 18-kD protein that consists of an 
amino-terminal RNA-binding domain and a carboxyl-terminal glycine-rich domain 
(Fujita, 1999; Lleonart, 2010). It exhibits structural similarity to a class of stress-induced 
RNA-binding proteins found in plants. Nishiyama et al. (1997) reported that cirp cDNA 
was induced at a low culture temperature of 32˚C in a mouse-derived cell line. In the last 
decade, a considerable number of cold-shock proteins have been identified in human 
cells; however, only 2 of these proteins, CIRP and RNA-binding motif protein 3 (RBM3), 
have been well characterized since their initial discovery. Although cirp expression was 
clearly identified in cell-based experiments, a comprehensive approach comparing MCAO 
rat brains with or without hypothermia did not identify the modulation of the cirp gene 
by hypothermia. We speculate that the experimental design of the in vivo ischemia-
hypothermia model may be not appropriate or that the changes in cirp gene expression 
were too small to be detected on oligonucleotide chips. Since Liu et al. (2010) reported that 
CIRP expression was upregulated even by ischemia alone, it might be difficult to see the 
difference in cirp gene expression between ischemia alone and ischemia plus hypothermia 
rat brains. We identified several transcription factors, including AP-1, Pax-4, lmo2, MyoD, 
ADR1, cdxA, and Pax-8, that have potential binding sites on the human and mouse cirp 
genome promoter regions (data not shown). Importantly, cold-inducible RNA-binding 
proteins, e.g., CIRP and RBM3, are also able to regulate their expression at the level of 
translation by binding to different transcripts, thus allowing the cell to respond rapidly to 
environmental signals. The binding of certain proteins to the 5′-untranslated region (UTR) 
or 3′-UTR of their mRNAs can affect the rate of translation initiation and the stability of 
the transcript. Xue et al. (1999) reported that hypothermia induces CIRP expression in the 
CNS in vitro (PC12 neuroblastoma cells) and in vivo (rat brains) and that oxidative stress 
and/or ischemia counteract this phenomenon. In contrast, Liu et al. (2010) reported no 
correlation between CIRP expression and brain metabolism; therefore, it is suggested that 
CIRP has unrevealed neuroprotective activity.  
More recently, Chip et al. (2011) reported that a low temperature (32˚C) induces the 
expression of a small subset of proteins, including RBM3. Immunohistochemistry of the 
developing postnatal murine brain revealed that the spatiotemporal neuronal expression 
pattern of RBM3 was very similar to that of doublecortin, a marker of neuronal precursor 
cells. Mild hypothermia profoundly promoted RBM3 expression and rescued neuronal cells 
from forced apoptosis, as observed in primary neurons, PC12 cells, and cortical organotypic 
slice cultures. Blocking RBM3 expression in neuronal cells by specific RBM3 small 
interfering RNAs significantly diminished the neuroprotective effects of hypothermia, while 
RBM3 overexpression reduced the cleavage of PARP, prevented internucleosomal DNA 
fragmentation, and reduced lactate dehydrogenase release, suggesting that RBM3 is a novel 
apoptosis modulator. Taken together, these data indicate that neuronal RBM3 induction in 
response to hypothermia apparently accounts for a substantial proportion of hypothermia-
induced neuroprotection. Therefore, they concluded that RBM3 may be one of the potential 
neuroprotective factors induced by hypothermia. 
3.5 Chaperones 
In response to various forms of stress, cells activate a highly conserved heat shock response 
in accordance with the induction of a set of heat shock proteins (Hsps) that play important 
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roles in cellular repair and protective mechanisms (Moseley, 2000). Evidence suggests that 
manipulation of the cellular stress response may offer strategies to protect brain cells from 
the damage that is encountered following cerebral ischemia or during the progression of 
neurodegenerative diseases. Hsp70 is a chaperone protein that can fold or refold proteins, 
coordinate protein trafficking, inhibit protein aggregation or degradation, and exhibits anti-
apoptotic and anti-inflammatory activities under physiological conditions. Over-expression 
of Hsp70 reduced ischemic injury in the mammalian brain (Marber et al., 1995; Zheng et al., 
2008). Investigation of the domains within Hsp70 that confer ischemic neuroprotection 
revealed the importance of the carboxyl-terminal domain (Sun et al., 2006). Arimoclomol, a 
co-inducer of Hsps, delayed the progression of amyotrophic lateral sclerosis in a mouse 
model in which motor neurons in the spinal cord and motor cortex degenerate (Kieran et al., 
2004). Celastrol, a promising candidate as an agent to counter neurodegenerative diseases, 
induced the expression of a set of Hsps in differentiated neurons grown in tissue culture 
(Chow and Brown, 2007). Heat shock “preconditioning” protected the nervous system at the 
functional level of the synapse, and selective over-expression of Hsp70 enhanced the level of 
synaptic protection (Ge et al., 2008). Following hyperthermia, constitutively expressed 
Hsc70 increased in synapse-rich areas of the brain where it associates with Hsp40 to form a 
complex that can refold denatured proteins. Stress tolerance in neurons is not solely 
dependent on their own Hsps, but can be supplemented by Hsps from adjacent glial cells; 
hence, the application of exogenous Hsps at neural injury sites is an effective strategy to 
maintain neuronal viability. 
We identified Hsp70 as a hypothermia-induced protein. Interestingly, we found that Hsp70 
was induced by hypothermia after ischemia, although hypothermia by itself did not induce 
Hsp70 in non-ischemic brains (Terao et al., 2009). Hsp27 was also induced by ischemia, but it 
was not induced by hypothermia. Other Hsps, including Hsp40, Hsp90, Grp78, Grp94, PDI, 
and ORP150, were detectable under normal conditions and were not affected by hypothermia 
or ischemia (Shintani et al., 2011). Recently, Hagiwara et al. (2007) reported that mild 
hypothermia at 34°C increased the expression level of Hsp70 in LPS-stimulated RAW264.7 
cells, although IL-1ǃ, IL-6, and TNF-ǂ expression levels were reduced under the same 
conditions. In contrast, Tirapelli et al. (2010) recently reported the increase of Hsp70 protein 
and gene expression in 1 h MCAO rat brains and the role of neuroprotection with 
hypothermia. However, they showed that the number of Hsp70-positive cells in the ischemic 
areas was reduced by hypothermia. In our model, we observed the suppression of Hsp70 
mRNA expression by hypothermia, in contrast to the protein level of Hsp70, as observed by 
Tirapelli et al. (2010). Since we currently do not know the mechanism of induction or the 
neuroprotective roles of Hsp70 in hypothermia, it is worthy of further investigation.  
4. Autophagy 
Autophagy is a catabolic process whereby cells respond to energy stress by recycling 
intracellular components, e.g., proteins, ribosomes, lipids, and even entire organelles 
(Rabinowitz and White, 2010). In the presence of a sufficient nutrient supply, anabolic 
reactions predominate within cells, and the autophagy system is maintained at the low levels 
that are critical for normal cellular homeostasis and survival. Basal levels of autophagic flux 
are required to degrade long-lived proteins, lipid droplets, and dysfunctional organelles, 
particularly in post-mitotic cells, e.g., cardiomyocytes and neurons, where the capacity for 
regeneration is limited. However, autophagy is rapidly activated in response to starvation or is 
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induced either by an inadequate nutrient supply or by defects in growth factor signaling 
pathways; when cells are exposed to stress, such as starvation and hypoxia, autophagic 
mechanisms are triggered to liberate energy substrates and eliminate defective organelles. 
Apart from conditions of emergent nutrient scarcity, the acceleration of autophagy is often 
observed in other clinically important circumstances, including neurodegenerative disorders, 
cancer, misfolded protein accumulation, microbial invasion, and cardiovascular diseases (Beau 
et al., 2011). There is now increasing evidence that, under certain pathological conditions, 
autophagy is able to trigger and mediate programmed cell death (type II death) (Galluzzi et al., 
2008). Such cell death might be involved in the neuronal death observed after global and focal 
cerebral ischemia (Balduini et al., 2009 and Sheng et al., 2010). Recently, it was reported that 
delayed neuronal death occurring in the CA1 pyramidal layer of the gerbil hippocampus after 
ischemia is apoptotic in nature and autophagosomes/autolysosomes are abundant in these 
neurons before DNA fragmentation (Xu and Zhang, 2011), i.e., under ischemic conditions, 
autophagy follows the activation of the mitochondrial pathway of apoptosis; cytochrome c is 
released from mitochondria, and caspase-9/caspase-3 are activated. Turkmen et al. (2011) 
recently showed that autophagy and autophagic flux are reduced in cold ischemic kidneys 
treated with bafilomycin A1. Reduced autophagy and autophagic flux were associated with a 
significant reduction in apoptotic cell death. These results suggest that hypothermia is able to 
suppress the autophagic phenomena induced by ischemia; however, since the relationship 
between autophagy and hypothermia is not well understood, detail analyses should be 
conducted in the future.  
5. Conclusion 
Hypothermia is a strong therapeutic methodology for delaying and suppressing ischemic 
damage in the brain. However, as we do not clearly know the precise mechanisms of 
hypothermia, the technique is still a kind of art and its usage is very limited. To resolve this 
situation, we should clarify the detailed molecular mechanisms of hypothermia, identify the 
dominant effectors for neuroprotection, and substitute the function of hypothermia into a 
therapeutic drug. In this review, we summarized potential drug targets to be considered for 
developing “hypothermia-like” drugs. At the present time, as we speculate that these 
targets are still a piece of the whole picture, we should improve our analytical technology 
and identify critical factors that change the pathophysiological condition induced by 
ischemia into a hypothermic one.  
6. Acknowledgements 
The authors express their deep gratitude to Drs. S. Ohkawa, P. Chapman, H. Nagaya, M. 
Mori, and K. Hirai of the Pharmaceutical Research Division, Takeda Pharmaceutical 
Company, Ltd., for their stimulating interest and continuing encouragement during the 
course of this work. They also thank Drs. Y. Kiyota, H. Ohta, Y. Nakagaito, and A. Oda of 
the Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., who 
contributed to this project with their elegant techniques. 
7. References 
K. Akaji, S. Suga, T. Fujino, K. Mayanagi, J. Inamasu, T. Horiguchi, S. Sato, T. Kawase (2003) 
Effect of intra-ischemic hypothermia on the expression of c-Fos and c-Jun, and 
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
59 
DNA binding activity of AP-1 after focal cerebral ischemia in rat brain, Brain Res., 
975: 149-157. 
E. Ambrosini, S. Columba-Cabezas, B. Serafini, A. Muscella, F. Aloisi (2003) Astrocytes are 
the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 
in relapsing experimental autoimmune encephalomyelitis and in vitro, Glia, 41, 
290–300. 
M. Aoki, M. Tamatani, M. Yamaguchi, Y. Bando, L. Kasai, Y. Miyoshi, Y. Nakamura, M.P. 
Vitek, M. Tohyama, H. Tanaka, H. Sugimoto (2001) Hypothermia treatment 
restores glucose regulated protein 78 (GRP78) expression in ischemic brain, Brain 
Res. Mol. Brain Res., 95: 117-128. 
W. Balduini, S. Carloni, G. Buonocore (2009) Autophagy in hypoxia-ischemia induced brain 
injury: evidence and speculations, Autophagy, 5: 221-223. 
M. Balestrino (1995) Pathophysiology of anoxic depolarization: new findings and a working 
hypothesis, J. Neurosci. Methods, 59: 99-103. 
E. Bandera, M. Botteri, C. Sutton, K.R. Abrams, N. Latronico (2006) Cerebral blood flow 
threshold of ischemic penumbra and infarct core in acute ischemic stroke: a 
systematic review, Stroke, 37: 1334-1339.  
E. Baumann, E. Preston, J. Slinn, D. Stanimirovic (2009) Post-ischemic hypothermia 
attenuates loss of the vascular basement membrane proteins, agrin and SPARC, 
and the blood-brain barrier disruption after global cerebral ischemia, Brain Res., 
1269: 185-197. 
I. Beau, M. Mehrpour, P. Codogno (2011) Autophagosome and human diseases, Int. Biochem. 
Cell Biol., 43: 460-464. 
S.A. Bernard, T.W. Gray, M.D. Buist, B.M. Jones, W. Silvester, G. Gutteridge, K. Smith (2002) 
Treatment of comatose survivors of out-of-hospital cardiac arrest with induced 
hypothermia, N. Engl. J. Med., 346: 557–563. 
B.R. Broughton, D.C. Reutens, C.G. Sobey (2009) Apoptotic mechanisms after cerebral 
ischemia, Stroke, 40: 331-339. 
J. Bureš, O. Burešova, J. Krivănek (1974) Anoxic depolarization. In: The Mechanisms and 
Applications of Leao’s Spreading Depression of Electroencephalographic Activity, J. Bureš, 
O. Burešova, J. Krivănek, 72-86, Academia (Publishing House of the Czechoslovak 
Academy of Sciences) and Academic Press, Prague and New York. 
H.V. Carey, M.T. Andrews, S.L. Martin (2003) Mammalian hibernation: cellular and 
molecular responses to depressed metabolism and low temperature, Physiol Rev., 
83: 1153-81. 
A-G. Ceulemans, T. Zgavc, R. Kooijman, S. Hachimi-Idrissi, S. Sarre, Y. Michotte (2010) The 
dual role of the neuroinflammatory response after ischemic stroke: modulatory 
effects of hypothermia, J. Neuroinflamm., 7: 74-92. 
A-G. Ceulemans, T. Zgavc, R. Kooijman, S. Hachimi-idrissi, S. Sarre, Y. Michotte (2011) Mild 
hypothermia causes differential, time-dependent changes in cytokine expression 
and gliosis following endothelin-1-induced transient focal cerebral ischemia, J. 
Neuroinflamm., 31: 60. 
A.S. Charbonnier, N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, D. Maurer (1999) 
Macrophage inflammatory protein 3 is involved in the constitutive trafficking of 
epidermal langerhans cells. J. Exp. Med., 190: 1755–1768. 
T. Cherin, M. Catbagan, S. Treiman, R. Mink (2006) The effect of normothemic and 
hypothermic hypoxia-ischemia on brain hypoxanthine phosphoribosyl transferase 
activity, Neurol. Res., 28: 831-836. 
www.intechopen.com
 
Advances in the Treatment of Ischemic Stroke 
 
60
S. Chip, A. Zelmer, O.O. Ogunshola, U. Felderhoff-Mueser, C. Nitsch, C. Bűhrer, S. 
Wellmann (2011) The RNA-binding protein RBM3 is involved in hypothermia 
induced neuroprotection, Neurobiol. Dis., 43: 388-396. 
J.S. Choi, J. Park, K. Suk, C. Moon, Y.K. Park, H.S. Han (2011) Mild hypothermia attenulates 
intercellular adhesion molecule-1 induction via activation of extracellular signal-
regulated kinase-1/2 in a focal cerebral ischemia model, Stroke Res. Treat., 2011: 
846716. Epub 2011 Mar 16. 
A.M. Chow, I.R. Brown, (2007) Induction of heat shock proteins in differentiated human and 
rodent neurons by celastrol, Cell Stress Chaperones, 12: 237-244 
F. Colbourne, S.Y. Grooms, R.S. Zukin, A.M. Buchan, M.W. Bennett (2003) Hypothermia 
rescues hippocampal CA1 neurons ans attenuates down-regulation of the AMPA 
receptor GluR2 subunit after forebrain ischemia, Proc. Natl. Acad. Sci. USA, 100: 
2906-2910. 
D.N. Cook, D.M. Prosser, R. Forster, J. Zhang, N.A. Kuklin, S.J. Abbondanzo, X.D. Niu, S.C. 
Chen, D.J. Manfra, M.T. Wiekowski, L.M. Sullivan, S.R. Smith, H.B. Greenberg, 
S.K.Narula, M. Lipp, S.A. Lira (2000) CCR6 mediates dendritic cell localization, 
lymphocyte homeostasis, and immune responses in mucosal tissue, Immunity, 12: 
495–503. 
O. B. Dimitrijevic, S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic (2006) Effects of the 
chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion 
injury, J. Cereb. Blood Flow Metab., 26: 797–810. 
O. B. Dimitrijevic, S. M. Stamatovic, R. F. Keep, A.V. Andjelkovic (2007) Absence of the 
chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in 
mice, Stroke, 38: 1345–1353. 
J.P. Dreier (2011) The role of spreading depression, spreading depolarization and spreading 
ischemia in neurological disease, Nat. Med., 17: 439-447.  
Y. Durandy (2008) Pediatric myocardial protection, Curr. Opin. Cardiol., 23: 85-90. 
E. Eberspacher, C. Werner, K. Engelhard, M. Pape, L. Laacke, D. Winner, R. Hollweck, P. 
Hutzler, E. Kochs (2005) Long-term effects of hypothermia on neuronal cell death 
and the concentration of apoptotic proteins after incomplete cerebral ischemia and 
reperfusion in rats, Acta. Anaesthesiol Scand., 49: 477-487. 
E. Eberspacher, C. Werner, K. Engelhard, M. Pape, L. A. Gelb, P. Hutzler, J. Henke, E. Kochs 
(2003) The effect of hypothermia on the expression of the apoptosis-regulating 
protein Bax after incomplete cerebral ischemia and reperfusion in rats, J. Neurosurg. 
Anesthesiol., 15: 200-208. 
K.U. Freichs, C. Kennedy, L. Sokoloff, J.M. Hallenbeck (1994) Local cerebral blood flow 
during hibernation, a model of natural tolerance to "cerebral ischemia, J. Cereb. 
Blood Flow Metab., 14: 193-205. 
K.U. Freruchs, J.M. Hallenbeck (1998) Hibernation in ground squirrels induces state and 
species-specific tolerance to hypoxia and aglycemia: an in vitro study in 
hippocampal slices, J. Cereb. Blood Flow Metab., 18: 168-75. 
J. Fujita (1999) Cold shock response in mammalian cells, J. Mol. Microbiol. Biotechnol., 1: 243-
255. 
H. Fukuda, T. Tomimatsu, N. Watanabe, J.W. Mu, M. Kohzuki, M. Endo, E. Fujii, T. 
Kanzaki, Y. Murata (2001) Post-ischemic hypothermia blocks caspase-3 activation 
in the newborn rat brain after hypoxia-ischemia, Brain Res., 910: 187-191. 
O. Fukui, Y. Kinugasa, A. Fukuda, H. Fukuda, E. Tskitishvili, S. Hayashi, M. Song, T. 
Kanagawa, T. Hosono, K. Shimaya,  
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
61 
M.A. Yenari, H.S. Han (2006) Influence of hypothermia on post-ischemic inflammation: role 
of nuclear factor kappa B (NfkappaB), Neurochem. Int., 49: 164-169. 
O. Fukui, Y. Kinugasa, A. Fukuda, H. Fukuda, E. Tskitishvili, S. Hayashi, M. Song, T. 
Kanagawa, T. Hosono, K. Shimoya, Y. Murata (2006) Post-ischemic hypothermia 
reduced IL-18 expression and suppressed microglial activation in the immature 
brain, Brain Res., 1121: 35-45. 
Y. Furuichi, T. Noto, J.Y. Li, T. Oku, M. Ishiye, A. Moriguchi, I. Aramori, N. Matsuoka, S. 
Mutoh, T. Yanagihara (2004) Multiple modes of action of tacrolimus (FK506) for 
neuroprotective action on ischemic damage after transient focal cerebral ischemia 
in rats, Brain Res., 1014: 120–130. 
L. Galluzzi, E. Morselli, J.M. Vicencio, O. Kepp, N. Joza, N. Tajeddine, G. Kroemer (2008) 
Life, death and burial: multifaceted impact of autophagy, Biochem. Soc. Trans., 36: 
786-790. 
P.F. Ge, T.F. Luo, J.Z. Zhang, D.W. Chen, Y.X. Luan, S.L. Fu (2008) Ischemic preconditioning 
induces chaperone hsp70 expression and inhibits protein aggregation in the CA1 
neurons of rats, Neurosci. Bull., 24: 288-296. 
A.R. Green, T. Odergren, T. Ashwood (2003) Animal models of stroke: do they have value 
for discovering neuroprotective agents? Trend. Pharmacol. Sci., 24: 402–408. 
M. Gyngell, E. Busch, B. Schmitz, K. Kohno, T. Back, M. Hoehn-Berlage, K-A. Hossmann 
(1995) Evolution of acute focal cerebral ischemia in rats observed by localized 1H-
MRS, diffusion-weighted MRI, and electrophysiological monitoring, NMR Biomed., 
8: 206-214. 
A.H. de Haas, H.R. van Weering, E.K. de Jong, H.W. Boddeke, K.P. Biber (2007) Neuronal 
chemokines: versatile messengers in central nervous system cell interaction, Mol. 
Neurobiol., 36: 137–151. 
S. Hagiwara, H. Iwasaka, S. Matsumoto, T. Noguchi (2007) Changes in cell culture 
temperature alter release of inflammatory mediators in murine macrophagic 
RAW264.7 cells, Inflamm. Res., 56: 297–303. 
H. S. Han, M. Karabiyikoglu, S. Kelly, R. A. Sobel, M. A. Yenari (2003) Mild hypothermia 
inhibits nuclear factor-κB translocation in experimental stroke, J. Cereb. Blood Flow 
Metab., 23: 589-598. 
H.S. Han, Y. Qiao, M. Karabiyikoglu, R.G. Giffard, M.A. Yenari (2002) Influence of mild 
hypothermia on inducible nitric oxide synthase expression and reactive nitrogen 
production in experimental stroke and inflammation, J. Neurosci., 22: 3921-3928. 
K. Harada, T. Maekawa, R. Tsuruta, T. Kaneko, D. Sadamitsu, T. Yamashima, K.K. Yoshida 
(2002) Hypothermia inhibits translocation of CaM kinase II and PKC- 
isoforms and fodrin proteolysis in rat brain synaptosome during ischemia-
reperfusion, J. Neurosci. Res., 67: 664-669. 
M. Holzer (2008) Devices for rapid induction of hypothermia, Eur. J. Anaesthesiol. Suppl., 42: 
31-38. 
The Hypothermia after Cardiac Arrest Study Group (2002) Mild therapeutic hypothermia to 
improve the neurological outcome after cardiac arrest, N. Engl. J. Med., 346: 549–
556. 
W.W. Hu, Y. Du, C. Li, Y.J. Song, G.Y. Zhang (2008) Neuroprotection of hypothermia 
against neuronal death in rat hippocampus through inhibiting the increased 
assembly of GluR6-PSD95-MLK3 signaling module induced by cerebral 
ischemia/reperfusion, Hippocampus, 18: 386-397. 
www.intechopen.com
 
Advances in the Treatment of Ischemic Stroke 
 
62
J. Inamasu, S. Suga, S. Sato, T. Horiguchi, K. Akaji, K. Mayanagi, T. Kawase (2001) Intra-
ischemic hypothermia attenuates intercellular adhesion molecule-1 (ICAM-1) and 
migration of neutrophil, Neurol. Res., 23: 105-111. 
X. Ji, Y. Luo, F. Ling, R.A. Stetler, J. Lan, G. Cao, J. Chen (2007) Mild hypothermia 
diminishes oxidative DNA damage and pro-death signaling events after cerebral 
ischemia: a mechanism for neuroprotection, 12: 1737-1747. 
B. Jieyong, W. Zhong, Z. Shiming, Z. Dai, Y. Kato, T. Kanno, H. Sano (2006) Decompressive 
craniectomy and mild hypothermia reduces infarction size and counterregulates 
Bax and Bcl-2 expression after permanent focal ischemia in rats, Neurosurg. Rev., 29: 
168-172. 
N. Kawai, M. Okauchi, K. Morisaki, S. Nagao (2000) Effects of delayed intraischemic and 
post-ischemic hypothermia on a focal model of transient cerebral ischemia in rats, 
Stroke 31: 1982–1989. 
S. Kelly, D. Cheng, G.K. Steinberg, M.A. Yenari (2005) Mild hypothermia decreases GSK3 
expression following global cerebral ischemia, Neurocrit. Care, 2: 212-217. 
D. Kieran, B. Kalmar, J.R. Dick, J. Riddoch-Contreras, G. Burnstock, L. Greensmith (2004) 
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease 
progression in ALS mice, Nat. Med., 10: 402-405. 
H. Y. Kil, J. Zhang, C. A. Piantadosi (1996) Brain temperature alters hydroxyl radical 
production during cerebral ischemia/reperfusion in rats, J. Cereb. Blood Flow Metab., 
16: 100–106. 
J.Y. Kim, N. kim, M.A. yenari, W. Chang (2011) Mild hypothermia suppresses calcium-
sensing receptor (CaSR) induction following forebrain ischemia while increasing 
GABA-B receptor 1 (GABA-B-R1) expression, Transl. Stroke Res., 2: 195-201. 
Y. Koda, R. Tsuruta, M. Fujita, T. Miyauchi, K. Kaneda, M. Todani, T. Aoki, M. Shitara, T. 
Izumi, S. Kasaoka, M. Yuasa, T. Maekawa (2010) Moderate hypotheramia 
suppresses jugular venous superoxide anion radical, oxidative stress, early 
inflammation, and endothelial injury in forebrain ischemia/reperfusion rats, Brain 
Res., 1311: 197-205. 
P. Laloux (2001) Intravenous rtPA thrombolysis in acute ischemic stroke, Acta. Neurol. Belg, 
101: 88-95. 
C.S. Kidwell, D.S. Kiebeskind, S. Starkman, J.L. Saver (2001) Trends in acute ischemic stroke 
trials through the 20th century, Stroke, 32: 1349–1359. 
J.W. Lampe, L.B. Becker (2011) State of art in therapeutic hypothermia, Annu. Rev. Med., 62: 
79-93. 
S.M. Lee, H. Zhao, C.M. Maier, G.K. Steinberg (2009) The protective effect of early 
hypothermia on PTEN phosphorylation correlates with free radical inhibition in rat 
stroke, J. Cereb. Blood Flow Metab., 29: 1589-1600. 
J.E. Lee, Y.J. Yoon, M.E. Moseley, M.A. Yenari (2005) Reduction in levels of matrix 
metalloproteinases and increased expression of tissue inhibitor of 
metalloproteinase-2 in response to mild hypothermia therapy in experimental 
stroke, J. Neurosurg., 103: 289-297. 
J. Li, S. Benashski, L.D. McCullough (2011) Post-stroke hypothermia provides 
neuroprotection through inhibition of AMP-activated protein kinase, J. 
Neurotrauma., 28: 1281-1288. 
M. Liebetrau, D. Burggraf, H.K. Martens, M. Pichler, G.F. Hamann (2004) Delayed moderate 
hypothermia reduces calpain activity and beakdown of its substrate in 
experimental focal cerebral ischemia in rats, Neurosci. Lett., 357: 17-20. 
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
63 
M.E. Lieonart (2010) A new generation of proto-oncogenes: cold-inducible RNA binding 
proteins, Biochim. Biophys. Acta., 1805: 43-52. 
S. Lin, P.G. Rhodes, Z. Cai (2011) Whole body hypothermia broadens the therapeutic 
window of intranasally administered IGF-1 in a neonatal rat model of cerebral 
hypoxia-ischemia, Brain Res., 18: 246-256. 
A. Liu, Z. Zhang, A. Li, J. Xue (2010) Effects of hypothermia and cerebral ischemia on cold-
inducible RNA-binding protein mRNA expression in rat brain, Brain Res., 1347: 
104-110. 
L. Liu, J.Y. Kim, M.A. Koike, Y.J. Yoon, X.N. Tang, H. Ma, H. Lee, G.K. Steinberg, J.E. Lee, 
M.A. Yenari (2008) FasL shedding is reduced by hypothermia in experimental 
stroke, J. Neurochem., 106: 541-550. 
X.C. Lu, A.J. Williams, C. Yao, R. Berti, J.A. Hartings, R. Whipple, M.T. Vahey, R.G. 
Polavarapu, K.L. Woller, F.C. Tortella, J.R. Dave (2004) Microarray analysis of acute 
and delayed gene expression profile in rats after focal ischemic brain injury and 
reperfusion, J. Neurosci. Res., 77: 843–857. 
C.M. Maier, G.H. Sun, D. Cheng, M.A. Yenari, P.H. Chan, G.K. Steinberg (2002) Effects of 
mild hypothermia on superoxide anion production, superoxide dismutase 
expression, and activity following transient focal cerebral ischemia, Neurobiol. Dis., 
11: 28-42. 
M.S. Marber, R. Mestril, S.H. Chi, M.R. Sayen, D.M. Yellon, W.H. Dillmann (1995) 
Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse 
increases the resistance of the heart to ischemic injury, J. Clin. Invest., 95: 1446-1456. 
Y. Matsuo, H. Onodera, Y. Shiga, H. Shozuhara, M. Ninomiya, T. Kihara, T. Tamatani, M. 
Miyasaka, K. Kogure (1994) Role of cell adhesion molecules in brain injury after 
transient middle cerebral artery occlusion in the rat, Brain Res., 656: 344–352.  
P. Meybohm, M. Gruenewald, K.D. Zacharowski, M. Albrecht, R. Lucius, N. Fosel, J. 
Hensler, K. Zitta, B. Bein (2010) Mild hypothermia alone or in combination with 
anesthetic post-conditioning reduces expression of inflammatory cytokines in the 
cerebral cortex of pigs after cardiopulmonary resuscitation, Crit. Care, 14: R21. 
T. Miyazawa, A. Tamura, S. Fukui, K.A. Hossmann (2003) Effect of mild hypothermia on 
focal cerebral ischemia. Review of experimental studies, Neurol. Res., 25: 457–464. 
P. Moseley (2000) Stress proteins and the immune response, Immunopharmacology, 48: 299-
302. 
Y. Murata (2006) Post-ischemic hypothermia reduced IL-18 expression and suppressed 
microglial activation in the immature brain, Brain Res., 22: 35-45. 
S. Nagel, Y. Su, S. Horstmann, S, Heiland, H. Heiland, H. Gardner, J. Koziol, F.J. Martinez-
Torres, S. Wagner (2008) Minocycline and hypothermia for reperfusion injury after 
focal cerebral ischemia in the rats: effects on BBB breakdown and MMP expression 
in acute and subacute phase, Brain Res., 1188: 198-206. 
H. Nishiyama, H. Higashitsuji, H. Yokoi, K. Itoh, S. Danno, T. Matsuda, J. Fujita (1997) 
Cloning and characterization of human CIRP (cold-inducible RNA-binding 
protein) cDNA and chromosomal assignment of the gene, Gene, 204: 115-120. 
H. Ohta, Y. Terao, Y. Shintani, Y. Kiyota (2007) Therapeutic time window of post-
ischemicmild hypothermia and the gene expression associated with the 
neuroprotection in rat focal cerebral ischemia, Neuroscience Res., 57: 424–433. 
N.G. Pabello, S.J. Tracy, A. Snyder-keller, R.W. Keller (2005) Regional expression of 
constitutive and inducible transcription factors following transient focal ischemia 
in the neonatal rat: influence of hypothermia, Brain Res., 1038: 11-21. 
www.intechopen.com
 
Advances in the Treatment of Ischemic Stroke 
 
64
P.B. Phanithi, Y. Yoshida, A. Santana, M. Su, S. Kawamura, N. Yasui (2000) Mild 
hypothermia mitigates post-ischemic neuronal death following focal cerebral 
ischemia in rat brain: immunohistochemical study of Fas, caspase-3 and TUNEL, 
Neuropathology, 20: 105-111. 
K. H. Polderman (2004) Application of therapeutic hypothermia in the ICU, Intensive. Care 
Med., 30: 556-575. 
J.D. Rabinowitz, E. White (2010) Autophagy and metabolism, Science, 330: 1344-1348. 
W. Roste` ne, P. Kitabgi, S.M. Parsadaniantz (2007) Chemokines: a new class of 
neuromodulator? Nat. Rev. Neurosci., 8: 895–903. 
M. Schilling, J-K. Strecker, E.B. Ringelstein, W-R. Schäbitz, R. Kiefer (2009) The role of CC 
chemokine receptor 2 on microglia activation and blood-borne cell recruitment 
after transient focal cerebral ischemia in mice, Brain Res., 1289: 79-84. 
E. Schutyser, S. Struyf, J. Van Damme (2003) The CC chemokine CCL20 and its receptor 
CCR6, Cytokine Growth Factor Rev., 14: 409–426. 
R. Sheng, L.S. Zhang, R. Han, X.Q. Liu, B. Gao, Z.H. Qin (2010) Autophagy activation is 
associated with neuroprotection in a rat model of focal cerebral ischemic 
preconditioning, Autophagy, [Epub ahead of print] 
T. Shimohata, H. Zhao, J.H. Sung, G. Sun, D. Mochly-Rosen, G.K. Steinberg (2007) 
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the 
protective effect of hypothermia, J. Cereb. Blood Flow Metab., 27: 1463-1475. 
T. Shimohata, H. Zhao, G.K. Steinberg (2007) Epsilon PKC may contribute to the protective 
effect of hypothermia in a rat focal cerebral ischemia model, Stroke, 38: 375-380. 
Y. Shinatni, Y. Terao, H. Ohta (2011) Molecular mechanisms underlying hypothermia-
induced neuroprotection, Stroke Res. Treat., 2011: 1-9. 
G. G. Somjen (2001) Mechanisms of spreading depression and hypoxic spreading 
depression-like depolarization, Physiol. Rev., 81: 1065-1096. 
K.B. Storey (2003) Mammalian hibernation. Transcriptional and translational controls, Adv. 
Exp. Med. Biol., 543: 21-38. 
Y. Sun, Y.B. Ouyang, L. Xu, A.M. Chow, R. Anderson, J.G. Hecker, R.G. Giffard (2006) The 
carboxy-terminal domain of inducible Hsp70 protects from ischemic injury in vivo 
and in vitro, J. Cereb. Blood Flow Metab., 26: 937-950. 
T. Tanaka, T. Wakamatsu, H. Daijo, S. Oda, S. Kai, T. Adachi, S. Kizaka-Kondoh, K. Fukuda, 
K. Hirota (2010) Persisting mild hypothermia suppresses hypoxia-inducible factor-
1 protein synthesis and hypoxia-inducible factor-1-mediated gene expression, Am. 
J. Physiol. Regul. Integr. Comp. Physiol., 298: R661-671.  
M. Teilum, M. Krogh, T. Wieloch, G. Mattiasson (2007) Hypothermia affects translocation of 
numerous cytoplasmic proteins following global cerebral ischemia, J. proteome Res., 
6: 2822-2832. 
Y. Terao, H. Ohta, A. Oda, Y. Nakagaito, Y. Kiyota, Y. Shintani (2009) Macrophage 
inflammatory protein-3alpha plays a key role in the inflammatory cascade in rat 
focal cerebral ischemia, Neurosci. Res., 64: 75-82. 
Y. Terao, S. Miyamoto, K. Hirai, H. Kamiguchi, H. Ohta, M. Shimojo, Y. Kiyota, S. Asahi, Y. 
Sakura, Y. Shintani (2009) Hypothermia enhances heat-shock protein 70 production 
in ischemic brains, NeuroReport, 20: 745–749. 
A. Theodorsson, L. Holm, E. Theodorsson (2008) Hypothermia-induced increase in galanin 
concentrations and ischemic neuroprotection in the rat brain, Neuropeptides, 42: 79-
87. 
www.intechopen.com
 
Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia 
 
65 
D.P. Tirapelli, C.G. Carlotti, J.P. Leite, L.F. Tirapelli, B.O. Colli (2010) Expression of HSP70 in 
cerebral ischemia and neuroprotective action of hypothermia and ketoprofen, Arq. 
Neuropsiquiatr., 68: 592-596. 
T. Tomimatsu, H. Fukuda, M. Endo, N. Watanabe, J. Mu, M. Kohzuki, E. Fujii, T. Kanzaki, Y. 
Murata (2001) Effects of hypothermia on neonatal hypoxic-ischemic brain injury in 
the rat: phosphorylation of Akt, activation of caspase-3-like protease, Neurosci. Lett., 
312: 21-24. 
K. Turkmen, J. Martin, A. Akcay, Q. Nguyen, K. Ravichandran, S. Faubel, A. Pacic, D. 
Ljubanović, C.L. Edelstein, A. Jani (2011) Apoptosis and autophagy in cold 
preservation ischemia, Transplantation, 91: 1192-1197. 
U. Utans-Schneitz, H. Lorez, W.E. Klinkert, J. Da Silva, W. Lesslauer (1998) A Novel rat CC 
chemokine, identified by targeted differential display, is upregulated in brain 
inflammation, J. Neuroimmunol., 92: 179–190. 
K.K. Wang (2000) Calpain and caspase: can you tell the difference? Trends Neurosci., 23: 20–
26. 
G.J. Wang, H.Y. Deng, C.M. Maier, G.H. Sun, M.A. Yenari (2002) Mild hypothermia reduces 
ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation 
following experimental stroke, Neuroscience, 114: 1081–1090. 
C.M. Webster, S. Kelly, M.A. Koike, V.Y. Chock, R.G. Giffard, M.A. Yenari (2008) 
Inflammation and NFB activation is decreased by hypothermia following global 
cerebral ischemia, Neurobiol. Dis., 33: 301-312. 
P.L. Wood (1995) Microglia as a unique cellular target in the treatment of stroke: potential 
neurotoxic mediators produced by activated microglia, Neurol. Res., 17: 242–248. 
Z. Xiang, S. Thomas, G. Pasinetti (2007) Increased neuronal injury in transgenic mice with 
neuronal overexpression of human cyclooxygenase-2 is reversed by hypothermia 
and rofecoxib treatment, Curr. Neurovasc. Res., 4: 274-279. 
Y.C. Xie, C.Y. Li, T. Li, D.Y. Nie, F. Ye (2007) Effect of mild hypothermia on angiogenesis in 
rats with focal cerebral ischemia, Neurosci. Lett., 422: 87-90. 
M. Xu, H.L. Zhang (2011) Death and survival of neuronal and astrocytic cells in ischemic 
brain injury: a role of autophagy, Acta. Pharmacol., doi: 10. 1038/aps.2011.50.  
J.H. Xue, K. Nonoguchi, M. Fukumoto, T. Sato, H. Nishiyama, H. Higashitsuji, K. Itoh, J. 
Fujita (1999) Effects of ischemia and H2O2 on the cold stress protein CIRP 
expression in rat neuronal cells, Free Radic. Biol. Med., 27: 1238-1244. 
Y. Yanagawa, M. Kawakami, Y. Okada (2002) Moderate hypothermia alters interleukin-6 
and interleukin-1 reactions in ischemic brain in mice, Resuscitation, 53: 93-99. 
H. Yanamoto, I. Nagata, Y. Niitsu, Z. Zhang, J.H. Xue, N. Sakai, H. Kikuchi (2001) Prolonged 
mild hypothermia therapy protects the brain against permanent focal ischemia, 
Stroke, 32: 232–239. 
D. Yang, S. Guo, T. Zhang, H. Li (2009) Hypothermia attenuates ischemia/reperfusion-
induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK 
signaling, FEBS Lett., 583: 2500-2506. 
M.A. Yenari, T.M. Hemmen (2010) Therapeutic hypothermia for brain ischemia: where have 
we come and where do we go?, Stroke, 41: S72-74. 
M.A. Yenari, S. Iwayama, D. Cheng, G.H. Sun, M. Fujimura, Y. Morita-Fujimura, P.H. Chan, 
G.K. Steinberg, (2002) Mild hypothermia attenuates cytochrome c release but does 
not alter Bcl-2 expression or caspase activation after experimental stroke, J. Cereb. 
Blood Flow Metab., 22: 29-38. 
www.intechopen.com
 
Advances in the Treatment of Ischemic Stroke 
 
66
M.A. Yenari, H.S. Han (2006) Influence of hypothermia on post-ischemic inflammation: role 
of NFB, Neurochem. Int., 49: 164-169. 
H. Yoshida, H. Yanai, Y. Namiki, K. Fukatsu-Sasaki, N. Furutani, N. Tada (2006) 
Neuroprotective effects of edaravone: a novel free radical scavenger in 
cerebrovascular injury, CNS Drug Reviews, 12: 9–20. 
Z. Zhang, R.A. Sobel, D. Cheng, G.K. Steinberg, M.A. Yenari (2001) Mild hypothermia 
increases Bcl-2 protein expression following global cerebral ischemia, Brain Res. 
Mol. Brain Res., 95: 75-85. 
H. Zhang, C. Ren, X. Gao, T. Takahashi, R.M. Sapolsky, G.K. Steinberg, H. Zhao (2008) 
Hypothermia blocks -catenin degradation after focal ischemia in rats, Brain Res., 
1198: 182-187. 
H. Zhang, G. Xu, J. Zhang, S. Murong, Y. Mei, E. Tong (2010) Mild hypothermia reduces 
ischemic neuron death via altering the expression of p53 and bcl-2, Neurol. Res., 32: 
384-389. 
H. Zhao, T. Shimohata, J.Q. Wang, G. Sun, D.W. Schaal, R.M. Sapolsky, G.K. Steinberg 
(2005) Akt contributes to neuroprotection by hypothermia against cerebral 
ischemia in rats, J. Neurosci., 25: 9794-9806. 
H. Zhao, M.A. Yenari, D. Cheng, R.M. Sapolsky, G.K. Steinberg (2005) Moderate 
hypothermia (30 degree C) for surgery of acute type A aortic dissection, J. Cereb. 
Blood Flow Metab., 25: 1119-1129. 
H. Zhao, M.A. Yenari, D. Cheng, R.M. Sapolsky, G.K. Steinberg (2004) Mild postischemic 
hypothermia prolongs the time window for gene therapy by inhibiting cytochrome 
C release, Stroke, 35: 572-577. 
H. Zhao, J.Q. Wang, T. Shimohata, G. Sun, M.A. Yenari, R.M. Sapolsky, G.K. Steinberg 
(2007) Conditions of protection by hypothermia and effects on apoptotic pathways 
in a rat model of permanent middle cerebral artery occlusion, J. Neurosurg., 107: 
636-641. 
Z. Zheng, J.Y. Kim, H. Ma, J.E. Lee, M.A. Yenari (2008) Anti-inflammatory effects of the 70 
kDa heat shock protein in experimental stroke, J. Cereb. Blood Flow Metab., 28: 53-63. 
Z. Zheng, M. A. Yenari (2004) Post-ischemic inflammation: molecular mechanisms and 
therapeutic implications, Neurological Res., 26: 884–892. 
C. Zhu, X. Wang, F. Xu, L. Qiu, X. Cheng, G. Simbruner, K. Blomgren (2006) Intraischemic 
mild hypothermia prevents neuronal cell death and tissue loss after neonatal 
cerebral hypoxia-ischemia, Eur. J. Neurosci., 23: 387-393. 
M. Zoli, R. Grimaldi, R. Ferrari, I. Zini, L.F. Agnati (1997) Short- and long-term changes in 
striatal neurons and astroglia after transient forebrain ischemia in rats, Stroke, 28: 
1049–1059. 
www.intechopen.com
Advances in the Treatment of Ischemic Stroke
Edited by Dr. Maurizio Balestrino
ISBN 978-953-51-0136-9
Hard cover, 246 pages
Publisher InTech
Published online 02, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
In recent years research on ischemic stroke has developed powerful therapeutic tools. The novel frontiers of
stem cells therapy and of hypothermia have been explored, and novel brain repair mechanisms have been
discovered. Limits to intravenous thrombolysis have been advanced and powerful endovascular tools have
been put at the clinicians' disposal. Surgical decompression in malignant stroke has significantly improved the
prognosis of this often fatal condition. This book includes contributions from scientists active in this innovative
research. Stroke physicians, students, nurses and technicians will hopefully use it as a tool of continuing
medical education to update their knowledge in this rapidly changing field.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Yasushi Shintani and Yasuko Terao (2012). Molecular Mechanisms Underlying the Neuroprotective Effect of
Hypothermia in Cerebral Ischemia, Advances in the Treatment of Ischemic Stroke, Dr. Maurizio Balestrino
(Ed.), ISBN: 978-953-51-0136-9, InTech, Available from: http://www.intechopen.com/books/advances-in-the-
treatment-of-ischemic-stroke/molecular-mechanisms-involved-in-the-neuroprotective-effect-of-hypothermia-in-
cerebral-ischemia
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
